Human MICL/CLEC12A Antibody

MICL, also known as C-type lectin-like molecule-1 (CLL-1), Killer cell lectin-like receptor KLRL1 and C type lectin domain family 12, member A (CLEC12A), is a type II transmembrane highly glycosylated protein that contains a functional tyrosine-based inhibitory motif in its cytoplasmic tail. The gene for MICL has been mapped to the natural killer gene complex (NKC) on human chromosome 12p13.2. MICL contains a non-classic C-type domain that binds non-sugar ligands. It is primarily expressed on NK cells, T cells, dendritic cells, monocytes and macrophages. By alternative splicing, multiple splice isoforms exist. MICL is a negative regulator of granulocytes and monocyte function and inhibits NK cell cytotoxicity. The amino acid sequence of human MICL extracellular domain is 53%, 65% and 55% identical to that of mouse, canine and bovine MICL, respectively.